Literature DB >> 16261455

Bone mineral density in girls and boys at different pubertal stages: relation with gonadal steroids, bone formation markers, and growth parameters.

Dilek Yilmaz1, Betül Ersoy, Elvan Bilgin, Gül Gümüşer, Ece Onur, Erbay Dundar Pinar.   

Abstract

Puberty has a key role in bone development. During puberty, several nutritional and hormonal factors play a major role in this process. The aim of this study was to determine the changes in areal bone mineral density (BMD), gonadal steroids, bone formation markers, and growth parameters in healthy Turkish pubertal girls and boys at different pubertal stages. In additional, we aimed to detect the relationship between BMD, sex steroids, and growth parameters, and to reveal the most important determinant of BMD in the pubertal period. BMD of the lumbar spine and total body was performed by dual-energy X-ray absorptiometry (Lunar DPX series) in 174 healthy pubertal children (91 girls, 83 boys), aged 11-15 years. Height and weight were measured. Pubertal stages were assesed. Bone formation markers and gonadal steroids were measured. BMD values significantly increased until stage IV in girls. In boys, BMD values also increased during puberty (P < 0.05), but it was significantly higher in stage IV compared with that in other pubertal stages (P < 0.01). Testosterone levels increased until stage IV in both sexes, particularly in boys. Estrogen levels significantly increased during puberty in girls, whereas it was significantly higher at stage IV in boys (P < 0.001). Bone-specific alkaline phosphatase (BAP) level was higher in early and midpuberty, and decreased in late puberty in girls (P < 0.001). BAP level was higher in stage IV in boys. Osteocalcin level was shown not to change significantly in pubertal stages. There was a modest correlation between BMD values and estrogen and testosterone levels in boys. In girls, there was a correlation between BMD values and estrogen levels only (P < 0.05). Weight was significantly associated with BMD in both sexes (P < 0.05). Estrogen had a significant influence on BMD in boys and girls. In conclusion, bone mass increased throughout puberty in both sexes. Peak bone mass was not achieved in girls, but was obtained at stage IV in boys. Bone formation markers were good predictors of bone mass in girls, but not in boys. Estrogen level made the greatest contribution to bone mineral acquisition in boys and girls. The achievement of peak bone mass was sustained by estrogen in boys. The major independent determinant of BMD in both sexes was weight.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16261455     DOI: 10.1007/s00774-005-0631-6

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  39 in total

1.  Calcitriol and bone mass accumulation in females during puberty.

Authors:  J Z Ilich; N E Badenhop; T Jelic; A C Clairmont; L A Nagode; V Matkovic
Journal:  Calcif Tissue Int       Date:  1997-08       Impact factor: 4.333

2.  Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency.

Authors:  J P Bilezikian; A Morishima; J Bell; M M Grumbach
Journal:  N Engl J Med       Date:  1998-08-27       Impact factor: 91.245

3.  Some remarks on bone mineralization.

Authors:  G B Forbes
Journal:  J Pediatr       Date:  1988-07       Impact factor: 4.406

4.  Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy.

Authors:  H Tobiume; S Kanzaki; S Hida; T Ono; T Moriwake; S Yamauchi; H Tanaka; Y Seino
Journal:  J Clin Endocrinol Metab       Date:  1997-07       Impact factor: 5.958

5.  Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development.

Authors:  S Mora; P Pitukcheewanont; F R Kaufman; J C Nelson; V Gilsanz
Journal:  J Bone Miner Res       Date:  1999-10       Impact factor: 6.741

6.  Evaluation of serum osteocalcin as an index of altered bone metabolism.

Authors:  K Kruse; U Kracht
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

Review 7.  Growth and pubertal development in children and adolescents: effects of diet and physical activity.

Authors:  A D Rogol; P A Clark; J N Roemmich
Journal:  Am J Clin Nutr       Date:  2000-08       Impact factor: 7.045

8.  Whole body bone mineral accretion in healthy children and adolescents.

Authors:  C Mølgaard; B L Thomsen; K F Michaelsen
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

9.  Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters.

Authors:  C Glastre; P Braillon; L David; P Cochat; P J Meunier; P D Delmas
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

10.  Low calcium intake is associated with decreased adrenal androgens and reduced bone age in premenarcheal girls in the last pubertal stages.

Authors:  Daniela Bonofiglio; Cecilia Garofalo; Stefania Catalano; Stefania Marsico; Saveria Aquila; Sebastiano Andò
Journal:  J Bone Miner Metab       Date:  2004       Impact factor: 2.626

View more
  40 in total

1.  Gender- and region-specific variations of estrogen receptor α and β expression in the growth plate of spine and limb during development and adulthood.

Authors:  Xin-Feng Li; Shan-Jin Wang; Lei-Sheng Jiang; Li-Yang Dai
Journal:  Histochem Cell Biol       Date:  2011-11-06       Impact factor: 4.304

2.  Age-related distribution of bone and skeletal parameters in 1,322 Japanese young women.

Authors:  Seiya Orito; Tatsuhiko Kuroda; Yoshiko Onoe; Yasuto Sato; Hiroaki Ohta
Journal:  J Bone Miner Metab       Date:  2009-05-12       Impact factor: 2.626

3.  The associations between the changes in serum inflammatory markers and bone mineral accrual in boys with overweight and obesity during pubertal maturation: a 3-year longitudinal study in Estonian boys.

Authors:  E Mengel; V Tillmann; L Remmel; P Kool; P Purge; E Lätt; J Jürimäe
Journal:  Osteoporos Int       Date:  2018-06-01       Impact factor: 4.507

4.  Age-related apparent diffusion coefficients of lumbar vertebrae in healthy children at 1.5 T.

Authors:  Alexander Tschischka; Christoph Schleich; Johannes Boos; Markus Eichner; Jörg Schaper; Joel Aissa; Gerald Antoch; Dirk Klee
Journal:  Pediatr Radiol       Date:  2018-04-13

5.  Prepubertal OVX increases IGF-I expression and bone accretion in C57BL/6J mice.

Authors:  Kristen E Govoni; Jon E Wergedal; Robert B Chadwick; Apurva K Srivastava; Subburaman Mohan
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-23       Impact factor: 4.310

6.  Lumbar spine peak bone mass and bone turnover in men and women: a longitudinal study.

Authors:  J S Walsh; Y M Henry; D Fatayerji; R Eastell
Journal:  Osteoporos Int       Date:  2008-07-16       Impact factor: 4.507

7.  Bone mass and structure in adolescents with type 1 diabetes compared to healthy peers.

Authors:  M T Saha; H Sievänen; M K Salo; S Tulokas; H H Saha
Journal:  Osteoporos Int       Date:  2008-12-13       Impact factor: 4.507

8.  The relationships among bone health, insulin-like growth factor-1 and sex hormones in adolescent female athletes.

Authors:  Rita Gruodyte; Jaak Jürimäe; Meeli Saar; Toivo Jürimäe
Journal:  J Bone Miner Metab       Date:  2009-10-15       Impact factor: 2.626

9.  Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study.

Authors:  H William Kelly; Mark L Van Natta; Ronina A Covar; James Tonascia; Rebecca P Green; Robert C Strunk
Journal:  Pediatrics       Date:  2008-07       Impact factor: 7.124

10.  Vitamin D receptor gene FokI polymorphisms influence bone mass in adolescent football (soccer) players.

Authors:  Maria Eduarda L Diogenes; Flávia Fioruci Bezerra; Giselda M K Cabello; Pedro H Cabello; Laura M C Mendonça; Astrogildo V Oliveira Júnior; Carmen M Donangelo
Journal:  Eur J Appl Physiol       Date:  2009-09-16       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.